RE-AIM THERAPEUTICS LTD
Research and experimental development on biotechnology
RE-AIM THERAPEUTICS LTD
Research and experimental development on biotechnology
Contact & Details
Contact
Full company profile for RE-AIM THERAPEUTICS LTD (15689618), an active company based in United Kingdom. Incorporated 29 Apr 2024. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Net Assets, Total Assets & Total Liabilities (2025–2025)
Cash in Bank
£28.29k
Net Assets
-£14.06k
Total Liabilities
£78.66k
Turnover
N/A
Employees
1
Debt Ratio
122%
Financial History
Revenue, profit, EBITDA and key financial figures
2025 30 Apr Year End | |
|---|---|
| P&L | |
| Revenue | |
| Gross Profit | |
| Operating Profit | |
| Net Profit | |
| EBITDA | |
| Assets | |
| Cash | |
| Total Assets | |
| Liabilities | |
| Total Liabilities | |
| Key Metrics | |
| Employees | |
Funding
Fundraising & Grants
No fundraising or grants recorded
Investors (0)
No investor information available
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Fox, Justian Craig | Director | British | England | 2 Oct 2025 | Active |
| Mcgill, Iain | Director | British | United Kingdom | 16 Apr 2026 | Active |
| Tsai, John | Director | American | Switzerland | 2 Oct 2025 | Active |
See all 8 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (2)
Syncona Portfolio Limited
Unknown
- Ownership Of Shares 25 To 50 Percent
- Voting Rights 25 To 50 Percent
Asher Maroof
British
- Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors
Group Structure
Group Structure
Charges
Charges
No charges registered
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 14 May 2026 | Officers | Appointment of Mr Iain Mcgill as director on 16 Apr 2026 | |
| 13 May 2026 | Officers | Appointment of Dr Dhavalkumar Patel as director on 17 Feb 2026 | |
| 5 May 2026 | Confirmation Statement | Confirmation statement made on 28 Apr 2026 with updates | |
| 13 Mar 2026 | Officers | Change to director Dr Asher Maroof on 2 Oct 2025 | |
| 18 Feb 2026 | Officers | Termination of John Tsai as director on 18 Feb 2026 |
Appointment of Mr Iain Mcgill as director on 16 Apr 2026
Appointment of Dr Dhavalkumar Patel as director on 17 Feb 2026
Confirmation statement made on 28 Apr 2026 with updates
Change to director Dr Asher Maroof on 2 Oct 2025
Termination of John Tsai as director on 18 Feb 2026
Recent Activity
Latest Activity
Appointment of Mr Iain Mcgill as director on 16 Apr 2026
3 weeks ago on 14 May 2026
Appointment of Dr Dhavalkumar Patel as director on 17 Feb 2026
3 weeks ago on 13 May 2026
Confirmation statement made on 28 Apr 2026 with updates
1 months ago on 5 May 2026
Change to director Dr Asher Maroof on 2 Oct 2025
2 months ago on 13 Mar 2026
Termination of John Tsai as director on 18 Feb 2026
3 months ago on 18 Feb 2026